Revvity, Inc. (RVTY)
NYSE·Healthcare·Medical - Diagnostics & Research
$97.77
-3.17%
Mkt Cap $11.29B
Analyst Ratings
Buy
5
Hold
9
Sell
0
Price Target (23 analysts)
$115.14
Range $105.00 – $129.00
Implied Upside
+17.8%
Consensus $115.14 vs current $97.77